234 related articles for article (PubMed ID: 23761624)
1. MRI and MRS predictors of mild cognitive impairment in a population-based sample.
Kantarci K; Weigand SD; Przybelski SA; Preboske GM; Pankratz VS; Vemuri P; Senjem ML; Murphy MC; Gunter JL; Machulda MM; Ivnik RJ; Roberts RO; Boeve BF; Rocca WA; Knopman DS; Petersen RC; Jack CR
Neurology; 2013 Jul; 81(2):126-33. PubMed ID: 23761624
[TBL] [Abstract][Full Text] [Related]
2. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS.
Kantarci K; Weigand SD; Przybelski SA; Shiung MM; Whitwell JL; Negash S; Knopman DS; Boeve BF; O'Brien PC; Petersen RC; Jack CR
Neurology; 2009 Apr; 72(17):1519-25. PubMed ID: 19398707
[TBL] [Abstract][Full Text] [Related]
3. Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment.
Wu A; Sharrett AR; Gottesman RF; Power MC; Mosley TH; Jack CR; Knopman DS; Windham BG; Gross AL; Coresh J
JAMA Netw Open; 2019 May; 2(5):e193359. PubMed ID: 31074810
[TBL] [Abstract][Full Text] [Related]
4. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance spectroscopy and brain volumetry in mild cognitive impairment. A prospective study.
Fayed N; Modrego PJ; García-Martí G; Sanz-Requena R; Marti-Bonmatí L
Magn Reson Imaging; 2017 May; 38():27-32. PubMed ID: 27964994
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
[TBL] [Abstract][Full Text] [Related]
7. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
Waragai M; Moriya M; Nojo T
J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
[TBL] [Abstract][Full Text] [Related]
8. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
[TBL] [Abstract][Full Text] [Related]
9. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes.
Kantarci K; Petersen RC; Przybelski SA; Weigand SD; Shiung MM; Whitwell JL; Negash S; Ivnik RJ; Boeve BF; Knopman DS; Smith GE; Jack CR
Arch Neurol; 2008 Dec; 65(12):1621-8. PubMed ID: 19064749
[TBL] [Abstract][Full Text] [Related]
11. N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
Walecki J; Barcikowska M; Ćwikła JB; Gabryelewicz T
Med Sci Monit; 2011 Dec; 17(12):MT105-11. PubMed ID: 22129910
[TBL] [Abstract][Full Text] [Related]
12. Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort.
Chen Y; Denny KG; Harvey D; Farias ST; Mungas D; DeCarli C; Beckett L
Alzheimers Dement; 2017 Apr; 13(4):399-405. PubMed ID: 27590706
[TBL] [Abstract][Full Text] [Related]
13. Loss of fornix white matter volume as a predictor of cognitive impairment in cognitively normal elderly individuals.
Fletcher E; Raman M; Huebner P; Liu A; Mungas D; Carmichael O; DeCarli C
JAMA Neurol; 2013 Nov; 70(11):1389-95. PubMed ID: 24018960
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study.
Suriyajakryuththana W; Tuntiyatorn L; Teepprasarn N; Sukying C
J Med Assoc Thai; 2014 Apr; 97(4):407-14. PubMed ID: 24964683
[TBL] [Abstract][Full Text] [Related]
15. Association Between Amyloid-β, Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals.
Nadkarni NK; Tudorascu D; Campbell E; Snitz BE; Cohen AD; Halligan E; Mathis CA; Aizenstein HJ; Klunk WE
J Gerontol A Biol Sci Med Sci; 2019 Oct; 74(11):1753-1760. PubMed ID: 30957843
[TBL] [Abstract][Full Text] [Related]
16. Cognitive dispersion is a sensitive marker for early neurodegenerative changes and functional decline in nondemented older adults.
Bangen KJ; Weigand AJ; Thomas KR; Delano-Wood L; Clark LR; Eppig J; Werhane ML; Edmonds EC; Bondi MW
Neuropsychology; 2019 Jul; 33(5):599-608. PubMed ID: 30896235
[TBL] [Abstract][Full Text] [Related]
17. 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease.
Parnetti L; Lowenthal DT; Presciutti O; Pelliccioli GP; Palumbo R; Gobbi G; Chiarini P; Palumbo B; Tarducci R; Senin U
J Am Geriatr Soc; 1996 Feb; 44(2):133-8. PubMed ID: 8576501
[TBL] [Abstract][Full Text] [Related]
18. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
[TBL] [Abstract][Full Text] [Related]
19. N-acetyl-aspartate and Myo-inositol as Markers of White Matter Microstructural Organization in Mild Cognitive Impairment: Evidence from a DTI-
Valatkevičienė K; Levin O; Šarkinaitė M; Vints WAJ; Kunickaitė R; Danylė G; Kušleikienė S; Sheoran S; Česnaitienė VJ; Masiulis N; Himmelreich U; Gleiznienė R
Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832141
[TBL] [Abstract][Full Text] [Related]
20. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
Arlt S; Buchert R; Spies L; Eichenlaub M; Lehmbeck JT; Jahn H
Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):335-44. PubMed ID: 22940716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]